MCM
BSX icon

MV Capital Management’s Boston Scientific BSX Stock Holding History

MV Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.4K Sell
690
-115
-14% -$6.25K ﹤0.01% 410
2026
Q1 		$50.5K Sell
805
-37
-4% -$2.96K 0.01% 317
2025
Q4 		$80.3K Sell
842
-18
-2% -$1.76K 0.01% 261
2025
Q3 		$84K Sell
860
-24
-3% -$2.48K 0.01% 254
2025
Q2 		$95K Buy
884
+53
+6% +$5.36K 0.01% 246
2025
Q1 		$83.8K Buy
831
+7
+0.8% +$705 0.01% 255
2024
Q4 		$73.6K Buy
824
+6
+0.7% +$528 0.01% 259
2024
Q3 		$68.5K Buy
818
+4
+0.5% +$315 0.01% 270
2024
Q2 		$62.7K Buy
814
+96
+13% +$7.03K 0.01% 270
2024
Q1 		$49.2K Buy
718
+13
+2% +$836 0.01% 296
2023
Q4 		$40.8K Buy
705
+68
+11% +$3.63K 0.01% 322
2023
Q3 		$33.6K Buy
637
+35
+6% +$1.84K ﹤0.01% 327
2023
Q2 		$32.6K Buy
602
+56
+10% +$2.92K ﹤0.01% 341
2023
Q1 		$27.3K Buy
546
+145
+36% +$6.83K ﹤0.01% 354
2022
Q4 		$18.6K Buy
401
+107
+36% +$4.63K ﹤0.01% 357
2022
Q3 		$11K Buy
294
+147
+100% +$5.9K ﹤0.01% 431
2022
Q2 		$5K Sell
147
-329
-69% -$13.4K ﹤0.01% 549
2022
Q1 		$21K Buy
476
+210
+79% +$9.1K ﹤0.01% 332
2021
Q4 		$11K Sell
266
-158
-37% -$6.64K ﹤0.01% 422
2021
Q3 		$18K Buy
424
+208
+96% +$9.2K ﹤0.01% 324
2021
Q2 		$9K Buy
216
+181
+517% +$7.62K ﹤0.01% 379
2021
Q1 		$1K Buy
+35
New +$1.32K ﹤0.01% 339

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MV Capital Management's BSX Position: Q2 2026 in Review

MV Capital Management reduced its Boston Scientific (BSX) stake by 14% in Q2 2026, selling an estimated $6.25K and leaving 690 shares worth $29.4K. The position accounts for ﹤0.01% of the portfolio, ranked #410.

MV Capital Management first reported a position in BSX in Q1 2021 and has held it in 22 quarters since. The position peaked at $95K in Q2 2025. 1,482 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • MV Capital Management held 690 shares of Boston Scientific worth $29.4K as of Q2 2026.
  • MV Capital Management sold 115 Boston Scientific shares in Q2 2026, an estimated $6.25K.
  • Boston Scientific made up ﹤0.01% of MV Capital Management's portfolio in Q2 2026, its #410 holding.
  • MV Capital Management first reported a position in Boston Scientific in Q1 2021 and has held it in 22 quarters since.
  • MV Capital Management's Boston Scientific position peaked at $95K in Q2 2025.
  • 1,482 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.